巨噬細胞炎性蛋白3α(MIP3a)活性蛋白
Active Macrophage Inflammatory Protein 3 Alpha (MIP3a)
CCL20; CKb4; LARC; MIP3-A; SCYA20; ST38; Small Inducible Cytokine Subfamily A(Cys-Cys)Member 20; Beta-Chemokine Exodus-1; Liver And Activation-Regulated Chemokine
- 編號APA095Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點9.6
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1147 ¥ 2868 ¥ 5736 ¥ 17208 ¥ 43020
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Macrophage Inflammatory Protein 3 Alpha (MIP-3α), also known as LARC (liver and activation-regulated chemokine), Exodus-1 or CCL20, is a CC chemokine with a selective chemotactic activity for lymphocytes and dendritic cells (DCs). MIP3α is produced by activated cells, including monocytes, T cells, endothelial cells, epithelial cells, and fibroblasts and is expressed in liver, lung, and some lymphoid tissues. This chemokine elicits its effects on its target cells by binding to the chemokine receptor CCR7. It attracts certain cells of the immune system, including dendritic cells and antigen-engaged B cells, CCR7 central-memory T-Cells. Thus, chemotaxis?assay used 24-well microchemotaxis system was undertaken to detect the chemotactic effect of recombinant human MIP-3α on the Jurkat cell line. Briefly, Jurkat cells were seeded into the upper chambers (200μL cell suspension,106 cells/mL in RPMI 1640 with FBS free) and MIP-3α (0.01ng/mL, 0.1ng/mL, 1ng/mL, 10ng/mL,100ng/mL and 1000ng/mL diluted separately in serum free RPMI 1640 ) was added in lower chamber with a polycarbonate filter (8 μm pore size) used to separate the two compartments. After incubation at 37℃ with 5% CO2 for 2h, the filter was removed, then cells in low chamber were observed by inverted microscope at low magnification (×100) and the number of migrated cells were counted at high magnification (×400) randomly (five fields for each filter). Result shows MIP-3α is able to induce migration of Jurkat cells. The migrated Jurkat cells in low chamber at low magnification (×100) were shown in Figure 1. Five fields of each chamber were randomly chosen, and the migrated cells were counted at high magnification (×400). Statistical results?were shown in Figure 2. The optimum chemotaxis of recombinant human MIP-3α occurs at 1-10ng/mL.
Figure 2. The chemotactic effect of recombinant human MIP-3α on Jurkat cells
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA095Hu01 | 巨噬細胞炎性蛋白3α(MIP3a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA095Hu01 | 巨噬細胞炎性蛋白3α(MIP3a)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA095Hu02 | 巨噬細胞炎性蛋白3α(MIP3a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA095Hu02 | 巨噬細胞炎性蛋白3α(MIP3a)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA095Hu01 | 巨噬細胞炎性蛋白3α(MIP3a)多克隆抗體 | WB; IHC; ICC; IP. |
PAA095Hu02 | 巨噬細胞炎性蛋白3α(MIP3a)多克隆抗體 | WB; IHC; ICC; IP. |
LAA095Hu71 | 巨噬細胞炎性蛋白3α(MIP3a)多克隆抗體(生物素標記) | WB; IHC; ICC. |
LAA095Hu81 | 巨噬細胞炎性蛋白3α(MIP3a)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
MAA095Hu22 | 巨噬細胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu23 | 巨噬細胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu24 | 巨噬細胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu25 | 巨噬細胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu27 | 巨噬細胞炎性蛋白3α(MIP3a)單克隆抗體 | WB; IHC; ICC; IP. |
MAA095Hu21 | 巨噬細胞炎性蛋白3α(MIP3a)單克隆抗體 | WB,IHC |
SEA095Hu | 巨噬細胞炎性蛋白3α(MIP3a)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA095Hu | 巨噬細胞炎性蛋白3α(MIP3a)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA095Hu01 | 巨噬細胞炎性蛋白3α(MIP3a)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 |
參考文獻
雜志 | 參考文獻 |
Medicine (Baltimore). | Increased Serum Levels of Macrophage Inflammatory Protein-3α and Cystatin A Predict a Poor Prognosis of Nasopharyngeal Carcinoma [Pubmed:25396333] |
Cancer | Serum chemokine network correlates with chemotherapy in non-small cell lung cancer [PubMed: 25976768] |
American Journal of?Cancer?Research | CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. [pubmed:28560063] |
Biological Research | In vitro chemokine (CC motif) receptor 6-dependent non-inflammatory chemotaxis during spermatogenesis [10.1186:s40659-018-0161-z] |
BioMed Research International | Indoleamine 2, 3-Dioxygenase (IDO) Regulates Th17/Treg Immunity in Experimental IgA Nephropathy [] |